NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
TOP NEWS
»11/12/2009 [Industry news]
Instem opens new full service office in Shanghai

Instem, a leading provider of early drug development software solutions, has announced the establishment of an office in Shanghai to provide local customer support, service delivery, client management, development and sales support to the Chinese pharmaceutical and wider life sciences R&D market.

 
Instem, a leading provider of early drug development software solutions, has announced the establishment of an office in Shanghai to provide local customer support, service delivery, client management, development and sales support to the Chinese pharmaceutical and wider life sciences R&D market. As China competes with other emerging countries and positions itself to be one of the largest markets by 2020, the Chinese government has substantially increased its R&D budget for their local pharmaceutical industry. Additionally, the cost of preclinical research is about one-third of the US and Europe, which is attracting many foreign organizations and stimulating both domestic and inward investment to establish new facilities throughout the country. “Instem was the first western Toxicology/Pathology software supplier to enter the Chinese market and we have added three new clients in just the last 12 months,” said Mr Phil Reason, CEO at Instem. “To deliver the exceptional client experience and meet the demand in China during this period of national growth, we believe a local Instem office and team was necessary. I’m very encouraged by the support we are receiving from industry and the Chinese government, and aim to be the supplier of choice and partner for every preclinical facility within China.” Newly appointed to the position of General Manager in charge of Asian Operations, Ms Penny Stockley is managing the locally hired Instem staff and overseeing all Asian-Pacific activities out of the new offices. Well respected in the market and a 20-year veteran at Instem, Penny has recently relocated to Shanghai and will continue to forge strong relationships within industry and government while ensuring client success. The new offices of Instem are located in the Zhangjiang Hi-Tech Park in the Pudong area of Shanghai. In addition to traditional on-site deployments, Instem will be providing access to its software application over the Internet from a Shanghai-based data center. Professionally managed and recognized as a premier Tier 3 facility, the data center will enable Instem to deliver its Provantis preclinical solution as an all inclusive service to laboratories of any size with the highest levels of security, performance and support.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.